SIRT1 and breast cancer: For example, amurensin G inhibits SIRT1 and further suppresses FoxO1 and MDR1 expression in doxorubicin-resistant BC cells, which can potentiate the cellular uptake of doxorubicin and allow it to suppress oncogenic growth (Oh et al., 2010).